| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |